Look for Stryker to become involved in even more deal-making during the second half of 2024. That was the message, Kevin Lobo, the Kalamazoo, MI-based company’s CEO, said during a recent earnings call.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,